KA
Kandamkulngara Aneesh
About Kandamkulngara Aneesh
Data last updated:
Kandamkulngara Aneesh is a Director at Baylor Pharmaceutical Private Limited (since 2021). The company operates in Pharma. Baylor Pharmaceutical Private Limited reported revenue of ₹4.54 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 May 2021 | 2019 | ₹4.54 Cr (FY 2025) | Active |
Board colleagues of Kandamkulngara Aneesh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anoop Murali | 10423937 | Baylor Pharmaceutical Private Limited | Director |
| Cheruliyil Mithun Das | 10424001 | Baylor Pharmaceutical Private Limited | Director |
| Edadan Puthiyaveedu Suhesh | 09158223 | Baylor Pharmaceutical Private Limited | Director |
| Kalathilparambath Sujil | 10417972 | Baylor Pharmaceutical Private Limited | Director |
| Panni Prashob | 09086346 | Baylor Pharmaceutical Private Limited | Director |
| Sujesh Vallathana | 11004327 | Baylor Pharmaceutical Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kandamkulngara Aneesh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kandamkulngara Aneesh
Kandamkulngara Aneesh currently holds 1 directorship: Baylor Pharmaceutical Private Limited (Director, since 22 May 2021, revenue ₹4.54 Cr (FY 2025)).
Kandamkulngara Aneesh was first appointed on 22 May 2021 as Director at Baylor Pharmaceutical Private Limited.
The current boards of Kandamkulngara Aneesh's companies include Anoop Murali (Baylor Pharmaceutical Private Limited), Cheruliyil Mithun Das (Baylor Pharmaceutical Private Limited), Edadan Puthiyaveedu Suhesh (Baylor Pharmaceutical Private Limited), Kalathilparambath Sujil (Baylor Pharmaceutical Private Limited), Panni Prashob (Baylor Pharmaceutical Private Limited), Sujesh Vallathana (Baylor Pharmaceutical Private Limited).